• EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Average Rating of "Buy" from Analysts

    Source: Buzz FX / 23 Nov 2024 02:46:08   America/New_York


    EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Average Rating of "Buy" from Analysts Written by MarketBeat November 23, 2024 Share Link copied to clipboard. Shares of EyePoint Pharmaceuticals, Inc.
    Read more...
Share on,